AbbVie's market cap is currently $354.62B. The company's EPS TTM is $2.391; its P/E ratio is 84.04; and it has a dividend yield of 3.21%. AbbVie is scheduled to report earnings on January 31, 2025, and the estimated EPS forecast is $2.52. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 0.00	$ 54.32B	$ 58.05B	$ 56.20B	$ 45.80B
Gross Profit	$ 0.00	$ 33.90B	$ 40.64B	$ 38.75B	$ 30.42B
Operating Income	$ 0.00	$ 12.76B	$ 18.12B	$ 17.92B	$ 11.36B
EBITDA	$ 0.00	$ 17.31B	$ 31.42B	$ 28.28B	$ 21.15B
Net Income	$ 4.28B	$ 4.86B	$ 11.84B	$ 11.54B	$ 4.62B
Balance Sheet
Cash & Short-Term Investments	$ 5.55B	$ 12.82B	$ 9.23B	$ 9.83B	$ 8.48B
Total Assets	$ 135.16B	$ 134.71B	$ 138.81B	$ 146.53B	$ 150.56B
Total Debt	$ 67.14B	$ 59.38B	$ 63.27B	$ 76.68B	$ 86.06B
Net Debt	$ 61.62B	$ 46.57B	$ 54.07B	$ 66.94B	$ 77.61B
Total Liabilities	$ 131.80B	$ 124.31B	$ 121.52B	$ 131.09B	$ 137.47B
Stockholders' Equity	$ 3.33B	$ 10.36B	$ 17.25B	$ 15.41B	$ 13.08B
Cash Flow
Free Cash Flow	$ 18.81B	$ 22.06B	$ 24.25B	$ 21.99B	$ 16.79B
Operating Cash Flow	$ 18.81B	$ 22.84B	$ 24.94B	$ 22.78B	$ 17.59B
Investing Cash Flow	$ -20.82B	$ -2.01B	$ -623.00M	$ -2.34B	$ -37.56B
Financing Cash Flow	$ -5.21B	$ -17.22B	$ -24.80B	$ -19.04B	$ -11.50B

Currency in USD

AbbVie Earnings and Revenue History

Income Statement >

AbbVie Debt to Assets

Balance Sheet >

AbbVie Cash Flow

Cash Flow >

AbbVie Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing